Generation 2.0 Monarch external Trigeminal Nerve Stimulation (eTNS) System®— 510(k) K233293

Substantially Equivalent

Neurosigma, Inc.

FDA 510(k) clearance K233293 for Generation 2.0 Monarch external Trigeminal Nerve Stimulation (eTNS) System®, Substantially Equivalent on 2024-01-16. Applicant: Neurosigma, Inc..

Clearance details

Applicant: Neurosigma, Inc.
Product code: Code QGL
Advisory panel: Neurology
Date received: 2023-09-29
Decision date: 2024-01-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Los Angeles, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.